Gainers
-
Sunedison Semiconductor Ltd (NASDAQ: SEMI) rose
42.5 percent to $11.80 in pre-market trading as GlobalWafers Co., Ltd. agreed to buy SunEdison Semiconductor for US$12.00 per
share in cash. Citigroup upgraded SunEdison Semiconductor from Sell to Neutral.
-
Cobalt International Energy, Inc. (NYSE: CIE) shares
rose 23.8 percent to $1.30 in pre-market trading after gaining 5.99 percent on Wednesday.
-
Raptor Pharmaceutical Corp. (NASDAQ: RPTP) shares
rose 15.8 percent to $7.99 in pre-market trading. Retrophin Inc (NASDAQ: RTRX) is considering an acquisition of Raptor Pharmaceutical, according to
Bloomberg.
-
Immunomedics, Inc. (NASDAQ: IMMU) shares rose 9.4
percent to $3.14 in pre-market trading after the company reported that its preclinical study on enhancing IMMU-132 activity in
SN-38-resistant cancer cells increased the median survival of mice.
-
SCYNEXIS Inc (NASDAQ: SCYX) rose 8.9 percent to
$2.82 in pre-market trading after surging 25.73 percent on Wednesday.
-
NetApp Inc. (NASDAQ: NTAP) rose 8.3 percent to
$31.25 in pre-market trading as the company reported better-than-expected earnings for its fiscal first quarter on Wednesday.
-
Canadian Solar Inc. (NASDAQ: CSIQ) rose 8.1
percent to $13.20 in the pre-market trading session. Canadian Solar reported Q2 earnings of $0.68 per share on revenue of
$805.9 million.
-
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) rose
6.8 percent to $6.77. Cantor Fitzgerald initiated coverage on Arrowhead Pharmaceuticals with a Buy rating.
-
Staples, Inc. (NASDAQ: SPLS) rose 6.3 percent to
$9.22 in pre-market trading after dropping 7.07 percent on Wednesday.
-
L Brands Inc (NYSE: LB) rose 4 percent to $77.00 in
pre-market trading as the company posted upbeat earnings for its second quarter after market close on Wednesday.
-
Wal-Mart Stores, Inc. (NYSE: WMT) rose 3.4 percent
to $75.40 in pre-market trading as the company reported better-than-expected EPS and revenue for the second quarter. The
company updated its EPS forecast for the full year.
-
YY Inc (ADR) (NASDAQ: YY) rose 3.3 percent to
$50.70 in the pre-market trading session. YY reported a Q2 profit of $51.7 million and reported the resignation of Chairman Mr.
Jun Lei.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Cerulean Pharma Inc (NASDAQ: CERU) fell 61.3
percent to $1.06 in pre-market trading after the company reported failed CRLX101/Avastin trial results. Leerink Swann, Janney
Capital and JMP Securities downgraded the stock following the news.
-
Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares
fell 15.6 percent to $19.99 in pre-market trading as the company reported that it has received a CRL from the FDA for Biologics
License Application for AndexXa.
-
Juniper Pharmaceuticals Inc (NASDAQ: JNP) shares
dropped 15.3 percent to $6.03 in pre-market trading. Juniper Pharma reported that its Phase 2b trial of COL-1077 lidocaine
vaginal gel did not meet primary and secondary endpoints.
-
Aerie Pharmaceuticals Inc (NASDAQ: AERI) shares
fell 14.8 percent to $16 in pre-market trading.
-
Oncomed Pharmaceuticals Inc (NASDAQ: OMED) shares
fell 14 percent to $10.07 in pre-market trading. OncoMed priced an offering of 5.5 million shares at $10 per share.
-
Momo Inc (ADR) (NASDAQ: MOMO) fell 4.5 percent to
$14.88 in pre-market trading. Momo reported Q2 adjusted earnings of $0.03 per ADS and announced that the Buyer Group will
withdraw the non-binding go-private offer.
-
Agilent Technologies Inc (NYSE: A) shares fell 4
percent to $46.49 in the pre-market trading session. Agilent posted better-than-expected earnings for its third quarter.
However, the company reported downbeat quarterly sales and issued a weak FY16 guidance.
-
Twitter Inc (NYSE: TWTR) shares fell 2.5 percent to
$19.67 in pre-market trading. Evercore ISI Group downgraded Twitter from Hold to Sell and lowered the price target from $18.00
to $17.00.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.